1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   Response -  Analytic Code
   
   
3. Who will be able to view these files?
   Response - Researchers who provide a methodologically sound proposal.
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [lesadawman@gmail.com].
   


6. For how long will this data be available start date provided 22-05-2021 and end date provided 22-01-2026?
   Response - Beginning 3 months and ending 5 years following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - NIL

Nephrotic syndrome is a common problem in children with good prognosis, but the disease course is associated with significant morbidity due to multiple relapses and its associated complications. Almost 95% case of nephrotic syndrome are primary with no identified cause. Approximately 85 – 90% of children with idiopathic nephrotic syndrome are steroid responsive while 10 – 15 % are partial or steroid resistant nephrotic syndrome. Infections remain an important cause of mortality and morbidity in children with nephrotic syndrome. It triggers the onset of disease or relapses and may also be responsible for a poor response to steroid therapy. Infections can lead to repeated relapses, poor response to steroid therapy and prolonged hospitalization. Spontaneous bacterial peritonitis is a serious complication of nephrotic syndrome with an incidence of 2-6%, and overwhelming infection carries a mortality risk of 1 – 5%. It usually occurs within the first 2 years of diagnosis of nephrotic syndrome. Low serum albumin, ascites, and an impaired immune system predispose to peritonitis and most often it is multifactorial in origin. Majority of peritonitis are caused by encapsulated gram positive organisms, particularly streptococcus pneumoniae, but may also be caused by gram-negative organisms. We plan to do a pilot study, which will be an open labelled randomized control trial, on the efficacy, safety and cost of short course (5days) versus usual course (7days) antibiotic treatment of spontaneous bacterial peritonitis in children with nephrotic syndrome aged 3 to 14 years. It will be an RCT with one short course and one long course antibiotic regimen, which will be compared head to head in this study. This will help us in better understanding of the optimum duration of antibiotic needed to treat SBP and help in the decision making of further treatment plan. There is limited data on antibiotic duration for SBP in children with nephrotic syndrome as well as its correlation with the clinical outcome, hence the importance of this study.